| Form | Liquid |
|---|
| Host Species | Humanized |
|---|
| Clonality | Monoclonal |
|---|
| Isotype | IgG2-G4-kappa |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Concentration | 1mg/ml |
|---|
| Endotoxin Level | Please contact the lab for this information. |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Species Reactivity | Human |
|---|
| Target | OX-2 membrane glycoprotein, MOX2, MOX1, CD200 |
|---|
| Storage Buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Expression System | Mammalian Cells |
|---|
| Accession Number | P41217 |
|---|
| Background | Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research.<br>• Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors., PMID:11423130<br/>• Mox2 is a component of the genetic hierarchy controlling limb muscle development., PMID:10403250<br/> |
|---|
| Alternative Names | ALXN6000, Anti-CD200, hB7V3V2G2G4, 1073059-33-2 |
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|